David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.89% |
| 2 | Technology | 10.04% |
| 3 | Healthcare | 9.38% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
KRONOS Worldwide
KRO
$1.03B
| $1.12M | ﹤0.01% |
102,256
-54,330
| -35% | -$681K |
|
2602
Standex International
SXI
$3.69B
| $1.12M | ﹤0.01% |
14,030
+8,430
| +151% | +$686K |
|
2603
Travere Therapeutics
TVTX
$6.32B
| $1.11M | ﹤0.01% |
33,619
-6,081
| -15% | -$167K |
|
|
TNGO
2604
DELISTED
Tangoe, Inc.
TNGO
| $1.11M | ﹤0.01% |
88,525
-493
| -0.6% | -$6.62K |
|
2605
CALL
Generac Holdings
GNRC
$11.9B
| $1.11M | ﹤0.01% |
28,000
| – | – |
|
2606
FTI Consulting
FCN
$4.19B
| $1.11M | ﹤0.01% |
26,930
+11,523
| +75% | +$459K |
|
2607
Hanmi Financial
HAFC
$918M
| $1.11M | ﹤0.01% |
44,681
+15,564
| +53% | +$348K |
|
|
STNR
2608
DELISTED
STEINER LEISURE LTD
STNR
| $1.11M | ﹤0.01% |
20,599
+1,303
| +7% | +$65.7K |
|
|
NAME
2609
DELISTED
Rightside Group, Ltd.
NAME
| $1.11M | ﹤0.01% |
163,650
+1,029
| +0.6% | +$8.64K |
|
2610
KB Financial Group
KB
$42.4B
| $1.11M | ﹤0.01% |
33,668
+15,244
| +83% | +$550K |
|
2611
Curtiss-Wright
CW
$22.5B
| $1.11M | ﹤0.01% |
+15,279
| New | +$1.13M |
|
2612
Westamerica Bancorp
WABC
$1.34B
| $1.1M | ﹤0.01% |
21,763
-6,019
| -22% | -$277K |
|
2613
Abbott
ABT
$201B
| $1.1M | ﹤0.01% |
22,451
-54,946
| -71% | -$2.64M |
|
2614
Landstar System
LSTR
$6.06B
| $1.1M | ﹤0.01% |
16,430
+10,960
| +200% | +$712K |
|
|
DSCI
2615
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $1.1M | ﹤0.01% |
153,172
+90,866
| +146% | +$683K |
|
2616
British American Tobacco
BTI
$122B
| $1.1M | ﹤0.01% |
20,256
+3,694
| +22% | +$204K |
|
2617
CALL
Itaú Unibanco
ITUB
$84.4B
| $1.09M | ﹤0.01% |
249,441
| – | – |
|
|
YDKN
2618
DELISTED
Yadkin Financial Corporation
YDKN
| $1.09M | ﹤0.01% |
52,286
-2,265
| -4% | -$45.7K |
|
|
ARNA
2619
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.09M | ﹤0.01% |
23,547
-89,312
| -79% | -$3.87M |
|
|
AV
2620
DELISTED
Aviva Plc
AV
| $1.09M | ﹤0.01% |
70,026
+20,030
| +40% | +$326K |
|
2621
Tennant Co
TNC
$1.19B
| $1.09M | ﹤0.01% |
+16,673
| New | +$1.09M |
|
2622
Hovnanian Enterprises
HOV
$747M
| $1.09M | ﹤0.01% |
16,356
-11,466
| -41% | -$903K |
|
2623
Matrix Service
MTRX
$303M
| $1.09M | ﹤0.01% |
59,520
+21,783
| +58% | +$427K |
|
|
IPHI
2624
DELISTED
INPHI CORPORATION
IPHI
| $1.09M | ﹤0.01% |
47,609
-38,435
| -45% | -$854K |
|
2625
TherapeuticsMD
TXMD
$26.4M
| $1.09M | ﹤0.01% |
2,764
+2,214
| +403% | +$781K |
|
Similar funds
David Shaw's Q2 2015 Portfolio in Review
As of Q2 2015, David Shaw held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw's Q2 2015 filing shows 504 new, 1,541 increased, 1,229 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
- David Shaw's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- David Shaw added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- David Shaw's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- David Shaw fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- David Shaw's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- David Shaw opened 504 new positions and closed 364 in Q2 2015.
- David Shaw's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.